Abacus Global Management, Inc. (ABX) Stock Analysis

ABX’s principal competitive advantages stem from its regulatory footprint, proprietary data, integrated business model, and capital efficiency. The company holds life settlement provider licenses in 49 states, a barrier that restricts new entrants and enables ABX to source policies at scale—over $10 billion in face value since inception. Its 20-year proprietary mortality and policy database underpins both pricing accuracy and the AI-driven LifeARC platform, which delivers individualized lifespan modeling. This data advantage is difficult for rivals to replicate and supports superior underwriting and risk management.

ABX’s vertical integration—spanning origination, asset management, technology, and wealth advisory—enables it to capture value across the life settlement value chain. For example, Abacus Intel’s mortality verification platform boasts 97% national coverage and less than 1% error rates, supporting both internal operations and external SaaS revenue streams. The company’s book turnover of 2.0x/year and realized gains of 20–25% on policy sales compare favorably to peers such as Coventry and GWG Holdings, which lack ABX’s breadth of data and integrated distribution.

Customer satisfaction is reinforced by a national advisor network and digital origination tools, while a high employee ownership rate (nearly 80%) fosters alignment and retention. However, switching costs for institutional clients are moderate, and regulatory or data privacy changes remain ongoing threats. Overall, ABX’s scale, data, and operational integration provide a defensible, though not unassailable, moat.